Göran Tornling

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: WORLD ALLERGY ORGANIZATION JOURNAL. 2024;17(4):100896
Disease burden and unmet need for acute allergic reactions - A patient perspective
Andersson E; Lofvendahl S; Olofsson S; Wahlberg K; Bjermer L; Tornling G; Janson C; Hjelmgren J
Article: RHEUMATOLOGY. 2024;:keae049
A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's
Tornling G; Edenius C; Pauling JD; Denton CP; Olsson A; Kowalski J; Murray A; Anderson M; Bhat S; Del Galdo F; Hall F; Korkosz M; Krasowska D; Olas J; Smith V; van Laar JM; Vonk MC; Wojteczek A; Herrick AL
Journal article: VALUE IN HEALTH. 2023;26(12):s200-s201
EE760 Using Discrete Choice Experiment to Elicit Treatment Preferences for Acute Allergic Reactions in Sweden: The Case of Patients with Swallowing Problems
Löfvendahl S; Andersson E; Tornling G; Olofsson S; Hjelmgren J
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(8):7478
Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats
Tornling G; Batta R; Salvail D; Raud J; Denton CP
Article: RHEUMATOLOGY. 2023;62(2):824-828
A phase 2 trial investigating the effects of the angiotensin II type 2 receptor agonist C21 in systemic sclerosis-related Raynaud's
Herrick AL; Batta R; Overbeck K; Raud J; Manning J; Murray A; Dinsdale G; Tornling G
Journal article: EUROPEAN HEART JOURNAL. 2022;43(Supplement_2):ehac544.3044
Investigation of the effect of the angiotensin II type 2 receptor (AT2R) agonist C21 on plasma NT-proBNP, a diagnostic biomarker, in subjects hospitalised with COVID-19
Batta R; Tornling G; Rosendahl E; Bengtsson T; Raud J
Journal article: RHEUMATOLOGY. 2022;61(Supplement_1):keac132.006
OA07 A Phase 2 randomised placebo-controlled trial investigating the effect of the angiotensin II type 2 receptor agonist C21 on cold-induced vasoconstriction in patients with Raynaud's phenomenon secondary to systemic sclerosis
Herrick AL; Batta R; Overbeck K; Raud J; Manning J; Dinsdale G; Murray A; Tornling G
Article: ECLINICALMEDICINE. 2021;41:101152
Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial
Tornling G; Batta R; Porter JC; Williams B; Bengtsson T; Parmar K; Kashiva R; Hallberg A; Cohrt AK; Westergaard K; Dalsgaard C-J; Raud J
Article: ARTHRITIS & RHEUMATOLOGY. 2021;73(1):61-68
Respiratory Diseases as Risk Factors for Seropositive and Seronegative Rheumatoid Arthritis and in Relation to Smoking
Kronzer VL; Westerlind H; Alfredsson L; Crowson CS; Nyberg F; Tornling G; Klareskog L; Holmqvist M; Askling J
Article: INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH. 2018;91(3):285-291
Cancer incidence in Stockholm firefighters 1958-2012: an updated cohort study
Kullberg C; Andersson T; Gustavsson P; Selander J; Tornling G; Gustavsson A; Bigert C
Article: EUROPEAN RESPIRATORY JOURNAL. 2017;49(1):1600345
Differences in regional air trapping in current smokers with normal spirometry
Karimi R; Tornling G; Forsslund H; Mikko M; Wheelock AM; Nyren S; Skold CM
Article: DRUG DESIGN, DEVELOPMENT AND THERAPY. 2016;10:2759-2770
Two Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma
Kuna P; Bjermer L; Tornling G
Article: ARTHRITIS & RHEUMATOLOGY. 2015;67(11):2845-2854
Risk Factors for the Rapid Increase in Risk of Acute Coronary Events in Patients With New-Onset Rheumatoid Arthritis: A Nested Case-Control Study
Mantel A; Holmqvist M; Nyberg F; Tornling G; Frisell T; Alfredsson L; Askling J
Article: JOURNAL OF RHEUMATOLOGY. 2014;41(4):792-798
Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease-related Interstitial Lung Diseases
Saketkoo LA; Mittoo S; Frankel S; LeSage D; Sarver C; Phillips K; Strand V; Matteson EL
Article: RESPIRATORY RESEARCH. 2014;15(1):23
Lung density on high resolution computer tomography (HRCT) reflects degree of inflammation in smokers
Karimi R; Tornling G; Forsslund H; Mikko M; Wheelock AM; Nyren S; Skold CM
Article: BMJ OPEN. 2014;4(1):e004018
Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study
Ekstrom M; Gustafson T; Boman K; Nilsson K; Tornling G; Murgia N; Toren K
Article: PLOS ONE. 2012;7(3):e34232
Cell Recovery in Bronchoalveolar Lavage Fluid in Smokers Is Dependent on Cumulative Smoking History
Karimi R; Tornling G; Grunewald J; Eklund A; Skold CM
Article: PLOS ONE. 2012;7(8):e43644
Bronchoalveolar Lavage Results Are Independent of Season, Age, Gender and Collection Site
Olsen HH; Grunewald J; Tornling G; Skold CM; Eklund A
Article: RESPIRATORY RESEARCH. 2011;12(1):48
Tenascin-C and alpha-smooth muscle actin positive cells are increased in the large airways in patients with COPD
Lofdahl M; Kaarteenaho R; Lappi-Blanco E; Tornling G; Skold MC
Journal article: INTERNATIONAL JOURNAL OF CLINICAL RHEUMATOLOGY. 2009;4(1):45-56
Pulmonary involvement in polymyositis and dermatomyositis
Tornling G; Fathi M; Lundberg IE
Journal article: CHEST. 2008;134(4):p129002-129P
SMOKING AND SEVERE PULMONARY FIBROSIS
Gustafson T; Boman K; Nilsson K; Strom K; Tornling G; Torén K
Article: ARTHRITIS & RHEUMATOLOGY. 2008;59(5):677-685
Interstitial lung disease in polymyositis and dermatomyositis: Longitudinal evaluation by pulmonary function and radiology
Fathi M; Vikgren J; Boijsen M; Tylen U; Jorfeldt L; Tornling G; Lundberg IE
Article: RESPIRATORY MEDICINE. 2007;101(10):2207-2212
Occupational exposure and severe pulmonary fibrosis
Gustafson T; Dahlman-Hoglund A; Nilsson K; Strom K; Tornling G; Toren K
Article: ARTHRITIS & RHEUMATOLOGY. 2007;56(1):372-383
Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies
Englund P; Wahlstrom J; Fathi M; Rasmussen E; Grunewald J; Tornling G; Lundberg IE
Article: INTERNATIONAL JOURNAL OF COPD. 2007;2(4):643-650
Detection of Chlamydia pneumoniae on cytospin preparations from bronchoalveolar lavage in COPD patients and in lung tissue from advanced emphysema.
Brandén E; Gnarpe J; Hillerdal G; Orre L; Sköld CM; Löfdahl M; Koyi H; Tornling G
Article: ANNALS OF OCCUPATIONAL HYGIENE. 2006;50(7):705-715
Large organic aerosols in a dynamic and continuous whole-body exposure chamber tested on humans and on a heated mannequin
Lundgren L; Skare L; Liden C; Tornling G
Article: RESPIRATORY MEDICINE. 2005;99(12):1511-1520
Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease
Campbell M; Eliraz A; Johansson G; Tornling G; Nihlén U; Bengtsson T; Rabe KF
Article: RESPIRATORY MEDICINE. 2005;99(1):20-26
Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD
Brandén E; Koyi H; Gnarpe J; Gnarpe H; Tornling G
Article: EUROPEAN RESPIRATORY JOURNAL. 2005;25(1):118-124
Accumulation of eosinophils and T-lymphocytes in the lungs after exposure to pinewood dust
Gripenbäck S; Lundgren L; Eklund A; Lidén C; Skare L; Tornling G; Grunewald J
Article: CHEST. 2004;125(3):916-923
Asthma treatment preference study: a conjoint analysis of preferred drug treatments.
Johansson G; Ställberg B; Tornling G; Andersson S; Karlsson GS; Fält K; Berggren F
Article: ANNALS OF THE RHEUMATIC DISEASES. 2004;63(3):297-301
Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis
Fathi M; Dastmalchi M; Rasmussen E; Lundberg IE; Tornling G
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2004;36(11-12):811-816
Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection
Brandén E; Koyi H; Gnarpe J; Gnarpe H; Tornling G
Article: EUROPEAN RESPIRATORY JOURNAL. 2003;22(4):578-583
Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid
Admyre C; Grunewald J; Thyberg J; Gripenbäck S; Tornling G; Eklund A; Scheynius A; Gabrielsson S
Article: AMERICAN JOURNAL OF INDUSTRIAL MEDICINE. 2003;44(1):75-82
Wheat flour exposure results in recruitment of inflammatory cells in the lungs of healthy individuals
Gripenbäck S; Lundgren L; Eklund A; Lidén C; Skare L; Tornling G; Grunewald J
Article: EUROPEAN RESPIRATORY JOURNAL. 2003;21(4):646-651
Lung accumulations of eosinophil granulocytes after exposure to cornstarch glove powder
Grunewald J; Eklund A; Katchar K; Moshfegh A; Lidén C; Lundgren L; Skare L; Tornling G
Article: EUROPEAN RESPIRATORY JOURNAL. 2002;20(5):1138-1146
Effects of formoterol and ipratropium bromide in COPD:: a 3-month placebo-controlled study
Wadbo M; Löfdahl CG; Larsson K; Skoogh BE; Tornling G; Arweström E; Bengtsson T; Ström K
Article: HUMAN AND EXPERIMENTAL TOXICOLOGY. 2000;19(7):402-411
Rat alveolar and interstitial macrophages in the fibrosing stage following quartz exposure
Zetterberg G; Elmberger G; Johansson A; Lundahl J; Lundborg M; Sköld CM; Tornling G; Camner P; Eklund A
Journal article: ANNALS OF WORK EXPOSURES AND HEALTH. 1998;42(8):541-547
A New Whole-body Exposure Chamber for Human Skin and Lung Challenge Experiments—the Generation of Wheat Flour Aerosols
ÉN C; Lundgren L; Skare L; Én G; Tornling G; Krantz S
Article: ANNALS OF OCCUPATIONAL HYGIENE. 1998;42(8):541-547
A new whole-body exposure chamber for human skin and lung challenge experiments - the generation of wheat flour aerosols
Liden C; Lundgren L; Skare L; Liden G; Tornling G; Krantz S
Article: THORAX. 1998;53(11):939-943
Environmental correlates of impaired lung function in non-smokers with severe α₁-antitrypsin deficiency (PiZZ)
Piitulainen E; Tornling G; Eriksson S
Article: EUROPEAN RESPIRATORY JOURNAL. 1998;12(4):825-830
Inhalation of cold air increases the number of inflammatory cells in the lungs in healthy subjects
Larsson K; Tornling G; Gavhed D; Muller-Suur C; Palmberg L
Article: AMERICAN JOURNAL OF PHYSIOLOGY. 1998;274(2):L226-L234
Differences between rat alveolar and interstitial macrophages 5 wk after quartz exposure
Zetterberg G; Johansson A; Lundahl J; Lundborg M; Sköld CM; Tornling G; Camner P; Eklund A
Article: AMERICAN JOURNAL OF INDUSTRIAL MEDICINE. 1997;32(4):332-336
Bronchoalveolar lavage findings in firefighters
Bergstrom CE; Eklund A; Skold M; Tornling G
Article: AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 1997;16(5):582-588
Functional, morphological, and phenotypical differences between rat alveolar and interstitial macrophages
Johansson A; Lundborg M; Skold CM; Lundahl J; Tornling G; Eklund A; Camner P
Article: THORAX. 1997;52(3):244-248
Effect of age and occupational exposure to airway irritants on lung function in nonsmoking individuals with alpha 1-antitrypsin deficiency (PiZZ)
Piitulainen E; Tornling G; Eriksson S
Article: HUMAN HEREDITY. 1996;46(4):221-225
Association between the p21 codon 31 A1 (arg) allele and lung cancer
Sjalander A; Birgander R; Rannug A; Alexandrie AK; Tornling G; Beckman G
Article: INFLAMMATION. 1995;19(5):543-548
UP-REGULATION OF ANTIGENS ON ALVEOLAR MACROPHAGES IN QUARTZ EXPOSED RATS
LUNDAHL J; EKLUND A; HALLGREN M; TORNLING G
Article: CARCINOGENESIS. 1995;16(9):2233-2236
P53 POLYMORPHISMS AND HAPLOTYPES IN LUNG-CANCER
BIRGANDER R; SJALANDER A; RANNUG A; ALEXANDRIE AK; SUNDBERG MI; SEIDEGARD J; TORNLING G; BECKMAN G; BECKMAN L
Article: ANNALS OF OCCUPATIONAL HYGIENE. 1995;39(4):441-454
AN INDEX OF PAST ASBESTOS EXPOSURE AS APPLIED TO CAR AND BUS MECHANICS
PLATO N; TORNLING G; HOGSTEDT C; KRANTZ S
Article: OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. 1995;52(3):192-195
EFFECTS WITHIN THE WEEK ON FORCED VITAL CAPACITY ARE CORRELATED WITH LONG-TERM CHANGES IN PULMONARY-FUNCTION - REANALYSIS OF STUDIES ON CAR PAINTERS EXPOSED TO ISOCYANATE
DAHLQVIST M; TORNLING G; PLATO N; ULFVARSON U
Article: INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH. 1995;67(5):343-346
OCCURRENCE OF PLEURAL PLAQUES IN WORKERS WITH EXPOSURE TO MINERAL WOOL
JARVHOLM B; HILLERDAL G; JARLIDEN AK; HANSSON A; LILJA BG; TORNLING G; WESTERHOLM P
Journal article: INFLAMMATION. 1994;18(5):547-563
SAWDUST-INDUCED INFLAMMATORY CHANGES IN RAT LUNG - EFFECTS ON ALVEOLAR AND INTERSTITIAL-CELLS IN RELATION TO TIME
JOHARD U; EKLUND A; HED J; JOHANSSON L; LUNDAHL J; SCHEYNIUS A; TORNLING G
Journal article: CARCINOGENESIS. 1994;15(9):1785-1790
GENETIC SUSCEPTIBILITY TO LUNG-CANCER WITH SPECIAL EMPHASIS ON CYP1A1 AND GSTM1 - A STUDY ON HOST FACTORS IN RELATION TO AGE AT ONSET, GENDER AND HISTOLOGICAL CANCER TYPES
ALEXANDRIE AK; SUNDBERG MI; SEIDEGARD J; TORNLING G; RANNUG A
Journal article: AMERICAN JOURNAL OF INDUSTRIAL MEDICINE. 1994;25(2):219-228
MORTALITY AND CANCER INCIDENCE IN STOCKHOLM FIRE FIGHTERS
TORNLING G; GUSTAVSSON P; HOGSTEDT C
Journal article: LAKARTIDNINGEN. 1993;90(40):3437-3440
[Malignant mesothelioma. New diagnostic and therapeutic methods make the disease curable].
Hillerdal G; Brodin O; Hjerpe A; Malina J; Mårtensson G; Strander H; Tornling G
Journal article: INFLAMMATION. 1993;17(4):511-519
PRESENCE OF SERUM MODULATES EXPRESSION OF COMPLEMENT RECEPTOR TYPE-1 (CR-1) ON HUMAN GRANULOCYTES AFTER QUARTZ EXPOSURE
LUNDAHL J; EKLUND A; HED J; TORNLING G; VITAS M
Journal article: BRITISH JOURNAL OF INDUSTRIAL MEDICINE. 1993;50(2):172-175
LONG-TERM EFFECTS OF ALUMINA ON COMPONENTS OF BRONCHOALVEOLAR LAVAGE FLUID FROM RATS
TORNLING G; BLASCHKE E; EKLUND A
Journal article: LAKARTIDNINGEN. 1990;87(7):477-479
[Increased risks of cancer can be explained by the type of occupation and life style].
Ahlbom A; Gerhardsson M; Hogstedt C; Lundberg I; Plato N; Steineck G; Tornling G
Journal article: IARC (INTERNATIONAL AGENCY FOR RESEARCH ON CANCER) SCIENTIFIC PUBLICATIONS. 1990;(97):113-119
Lung cancer incidence among Swedish ceramic workers with silicosis.
Tornling G; Hogstedt C; Westerholm P
Journal article: AMERICAN JOURNAL OF INDUSTRIAL MEDICINE. 1990;17(3):299-310
DECREASED LUNG-FUNCTION AND EXPOSURE TO DIISOCYANATES (HDI AND HDI-BT) IN CAR REPAIR PAINTERS - OBSERVATIONS ON REEXAMINATION 6 YEARS AFTER INITIAL STUDY
TORNLING G; ALEXANDERSSON R; HEDENSTIERNA G; PLATO N
Journal article: BRITISH JOURNAL OF INDUSTRIAL MEDICINE. 1989;46(11):782-786
CHARACTERISTICS OF ALVEOLAR CELLS AND SOLUBLE COMPONENTS IN BRONCHOALVEOLAR LAVAGE FLUID FROM NON-SMOKING ALUMINUM POTROOM WORKERS
EKLUND A; ARNS R; BLASCHKE E; HED J; HJERTQUIST SO; LARSSON K; LOWGREN H; NYSTROM J; SKOLD CM; TORNLING G
Journal article: SCANDINAVIAN JOURNAL OF WORK, ENVIRONMENT & HEALTH. 1989;15(4):296-301
LUNG-FUNCTION AND BRONCHIAL REACTIVITY IN ALUMINUM POTROOM WORKERS
LARSSON K; EKLUND A; ARNS R; LOWGREN H; NYSTROM J; SUNDSTROM G; TORNLING G
Journal article: HAEMATOLOGICA. 1988;73(5):407-409
BILATERAL PLEURAL EFFUSIONS DUE TO AMYLOIDOSIS IN A CASE OF WALDESTROMS MACROGLOBULINEMIA
LINDEMALM C; BIBERFELD P; CHRISTENSSON B; ERIKSSON C; HAVERLING M; TORNLING G; UNGE G; MELLSTEDT H
Journal article: EUROPEAN RESPIRATORY JOURNAL. 1988;1(5):469-470
ACQUIRED PROGRESSIVE ASTHMA IN A FIREFIGHTER
BERGSTROM CE; TORNLING G; UNGE G
Journal article: IN VIVO. 1988;2(2):143-146
DNA synthesis in the gastroduodenal mucosa during acute and chronic stress in the rat.
Rubio CA; Sveander M; Tornling G; Uribe A
Journal article: BRITISH JOURNAL OF INDUSTRIAL MEDICINE. 1987;44(7):443-445
HYALURONIC-ACID IN BRONCHOALVEOLAR LAVAGE IN RATS EXPOSED TO QUARTZ
TORNLING G; EKLUND A; ENGSTROMLAURENT A; HALLGREN R; UNGE G; WESTMAN B
Journal article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 1987;66(4):381-382
CHYLOTHORAX AS A COMPLICATION AFTER DELIVERY
TORNLING G; AXELSSON G; PETERFFY A
Journal article: ACTA PATHOLOGICA MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA - SECTION A PATHOLOGY. 1982;90(4):273-275
THE PROPHYLACTIC EFFECT OF DIPYRIDAMOLE ON THE SIZE OF MYOCARDIAL-INFARCTION FOLLOWING CORONARY-ARTERY OCCLUSION
ADOLFSSON J; TORNLING G; UNGE G; LJUNGQVIST A
Journal article: ACTA PATHOLOGICA MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA - SECTION A PATHOLOGY. 1982;90(4):269-271
CAPILLARY NEOFORMATION IN THE HEART OF DIPYRIDAMOLE-TREATED RATS
TORNLING G
Journal article: ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA - SECTION A PATHOLOGY. 1982;278:1-63
CAPILLARY NEOFORMATION IN THE HEART AND SKELETAL-MUSCLE DURING DIPYRIDAMOLE-TREATMENT AND EXERCISE
TORNLING G
Journal article: ALLERGY. EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 1982;37(1):29-39
DEFECTIVE SEROTONIN (5-HT) TRANSPORT MECHANISM IN PLATELETS FROM PATIENTS WITH ENDOGENOUS AND ALLERGIC-ASTHMA
MALMGREN R; GRUBBSTROM J; OLSSON P; THEORELL H; TORNLING G; UNGE G
Journal article: LIFE SCIENCES. 1981;29(25):2649-2658
DEFECTIVE SEROTONIN TRANSPORT MECHANISM IN PLATELETS FROM ENDOGENOUSLY DEPRESSED-PATIENTS
MALMGREN R; ASBERG M; OLSSON P; TORNLING G; UNGE G
Journal article: ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA - SECTION A PATHOLOGY. 1981;89(4):309-312
THE EFFECT OF INCREASED CARDIAC PRESSURE LOAD AND VOLUME LOAD ON THE SIZE OF MYOCARDIAL-INFARCTION FOLLOWING CORONARY-ARTERY OCCLUSION
TORNLING G; CARLSSON S; UNGE G; LJUNGQVIST A
Journal article: AGENTS AND ACTIONS. 1981;11(3):287-289
DIPYRIDAMOLE SUPPRESSES UPTAKE OF THYMIDINE IN HUMAN AND BOVINE CELLS-INVITRO
WIDSTROM O; BUSCH C; TORNLING G; NILSSON BS; UNGE G
Journal article: JOURNAL OF PHYSIOLOGY. 1981;310(JAN):529-532
CAPILLARY INCREASE IN THE SKELETAL-MUSCLE OF TRAINED YOUNG AND ADULT-RATS
ADOLFSSON J; LJUNGQVIST A; TORNLING G; UNGE G
Journal article: THROMBOSIS RESEARCH. 1980;18(5):733-741
THE 5-HYDROXYTRYPTAMINE TAKE-UP MECHANISM IN NORMAL PLATELETS AND PLATELETS FROM MIGRAINE AND ASTHMATIC-PATIENTS
MALMGREN R; OLSSON P; TORNLING G; UNGE G
Journal article: ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH. 1980;30-1(4):622-623
PROLIFERATIVE ACTIVITY OF CAPILLARY WALL CELLS IN SKELETAL-MUSCLE OF RATS DURING LONG-TERM TREATMENT WITH DIPYRIDAMOLE
TORNLING G; UNGE G; ADOLFSSON J; LJUNGQVIST A; CARLSSON S
Journal article: EXPERIMENTAL CELL RESEARCH. 1978;115(1):183-189
RAPID METHOD FOR ISOLATION OF VIABLE CARDIAC MYOCYTES FROM ADULT RAT
RAJS J; SUNDBERG M; SUNDBY GB; DANELL N; TORNLING G; BIBERFELD P; JAKOBSSON SW
Journal article: ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA - SECTION A PATHOLOGY. 1978;86(4):297-301
REACTION OF VASCULAR PATTERN OF HYPERTROPHIED MYOCARDIUM TO INCREASED CARDIAC VOLUME LOAD - MICRO-ANGIOGRAPHICAL STUDY
CARLSSON S; LJUNGQVIST A; TORNLING G; UNGE G
Journal article: ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA - SECTION A PATHOLOGY. 1978;86(2):117-119
MYOCARDIAL CAPILLARY VASCULATURE IN REPEATED PHYSICAL EXERCISE - EXPERIMENTAL INVESTIGATION IN RAT
CARLSSON S; LJUNGQVIST A; TORNLING G; UNGE G
Journal article: NEW ENGLAND JOURNAL OF MEDICINE. 1978;299(24):1366
TREATMENT OF DIABETIC NECROBIOSIS WITH ASPIRIN OR DIPYRIDAMOLE
UNGE G; TORNLING G
Journal article: ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA - SECTION A PATHOLOGY. 1978;86(1):82
DIPYRIDAMOLE AND CAPILLARY PROLIFERATION - PRELIMINARY-REPORT
TORNLING G; UNGE G; LJUNGQVIST A; CARLSSON S
Visa fler

Alla övriga publikationer

Conference publication: 2024;:a1055
Buloxibutid, A Novel Angiotensin II Type 2 Receptor Agonist, Stabilized and Improved Lung Function in Individuals With Idiopathic Pulmonary Fibrosis in the 36-week Phase 2 AIR Trial
Ganslandt C; Maher TM; Molyneaux PL; Lindmark BE; Raud J; Tornling G; Bengtsson T; Rosendahl E
Conference publication: 2023;:pa3501
An open-label, pharmacodynamic trial investigating vascular effects of the angiotensin II type 2 receptor (AT2R) agonist (ATRAG) C21
Ganslandt C; Rein-Hedin E; Sjöberg F; Tornling G; Bengtsson T; Overbeck K; Rosendahl E; Batta R; Bjerring B; Raud J; Dalsgaard C-J
Conference publication: 2023;:a6480
Development of Angiotensin II Type 2 Receptor Agonists 'ATRAGs' for Treatment of Pulmonary Fibrosis and Pulmonary Hypertension
Batta R; Raud J; Tornling G; Nygard M; Dalsgaard C-J
Conference publication: 2023;:a2531
An Updated Interim Analysis of the Air Trial; an Open-label, Single-arm, 36-week, Phase 2 Trial of an Angiotensin Type 2 Receptor Agonist, C21, in Individuals With IPF
Batta R; Maher TM; Ganslandt C; Tornling G; Bengtsson T; Pophale H; Rosendahl E
Conference publication: VALUE IN HEALTH. 2023;26(12):S200-S201
USING DISCRETE CHOICE EXPERIMENT TO ELICIT TREATMENT PREFERENCES FOR ACUTE ALLERGIC REACTIONS IN SWEDEN: THE CASE OF PATIENTS WITH SWALLOWING PROBLEMS
Lofvendahl S; Andersson E; Tornling G; Olofsson S; Hjelmgren J
Conference publication: 2022;:4402
Interim results from AIR, an open-label, single arm, 36-week ph 2 trial of C21 in subjects with idiopathic pulmonary fibrosis
Maher T; Ganslandt C; Batta R; Tornling G; Bengtsson T; Pophale H; Rosendahl E; Maher T
Conference publication: 2022;:1051
Non-interventional, retrospective, multi-center, follow-up study evaluating the effect of the angiotensin II type 2 receptor agonist C21 on lung pathology in subjects previously hospitalised with COVID-19
Batta R; Tornling G; Bengtsson T; Devaraj A; Kashiva R; Rajkondawar A; Parmar K; Bhalani N; Bohra A; Cohrt A; Ganslandt C
Conference publication: EUROPEAN HEART JOURNAL. 2022;43:3044
Investigation of the effect of the angiotensin II type 2 receptor (AT2R) agonist C21 on plasma NT-proBNP, a diagnostic biomarker, in subjects hospitalised with COVID-19
Batta R; Tornling G; Rosendahl E; Bengtsson T; Raud J
Conference publication: RHEUMATOLOGY. 2022;61
A PHASE 2 RANDOMISED PLACEBO-CONTROLLED TRIAL INVESTIGATING THE EFFECT OF THE ANGIOTENSIN II TYPE 2 RECEPTOR AGONIST C21 ON COLD-INDUCED VASOCONSTRICTION IN PATIENTS WITH RAYNAUD'S PHENOMENON SECONDARY TO SYSTEMIC SCLEROSIS
Herrick AL; Batta R; Overbeck K; Raud J; Manning J; Dinsdale G; Murray A; Tornling G
Preprint: MEDRXIV. 2021
The angiotensin type 2 receptor agonist C21 restores respiratory function in COVID19 - a double-blind, randomized, placebo-controlled Phase 2 trial
Tornling G; Batta R; Porter J; Bengtsson T; Parmar K; Kashiva R; Hallberg A; Cohrt AK; Westergaard K; Dalsgaard C-J; Raud J
Preprint: SSRN ELECTRONIC JOURNAL. 2021
Seven Days Treatment With the Angiotensin II Type 2 Receptor Agonist C21 in Hospitalized COVID-19 Patients: A Placebo-Controlled Randomized Phase 2 Trial
Tornling G; Batta R; Porter JC; Williams B; Bengtsson T; Parmar K; Kashiva R; Hallberg A; Cohrt AK; Westergaard K; Dalsgaard C-J; Raud J
Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020;22(1):E225-225
Pathological Insight into 5-HT_2B Receptor Activation in Fibrosing Interstitial Lung Diseases
Lofdahl A; Tornling G; Wigen J; Larsson-Callerfelt A-K; Wenglen C; Westergren-Thorsson G
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:1099
INHIBITION OF MICROSOMAL PROSTAGLANDIN E SYNTHASE-1 (MPGES-1) BY GS-248 REDUCES PROSTAGLANDIN E2 BIOSYNTHESIS WHILE INCREASING PROSTACYCLIN IN HUMAN SUBJECTS
Edenius C; Ekstrom G; Kolmert J; Morgenstern R; Stenberg P; Jakobsson PJ; Tornling G
Letter: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2016;194(1):118-120
Effect of Anti-IL-13 Treatment on Airway Dimensions in Severe Asthma
Brightling CE; Nordenmark LH; Jain M; Piper E; She D; Braddock M; Colice G; Tornling G
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:632
WHAT DRIVES THE RAPID INCREASE IN RISK OF ACUTE CORONARY SYNDROME FOLLOWING RA DIAGNOSIS?
Mantel A; Holmqvist M; Nyberg F; Tornling G; Frisell T; Alfredsson L; Askling J
Review: SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. 2007;28(4):451-458
Pulmonary complications of polymyositis and dermatomyositis
Fathi M; Lundberg IE; Tornling G
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2006;54(9):S659
Longitudinal evaluation of interstitial lung disease in polymyositis and dermatomyositis.
Lundberg IE; Fathi M; Vikgren J; Boijsen M; Tylen U; Jorfeldt L; Tornling G
Meeting abstract: VALUE IN HEALTH. 2003;6(6):611
Asthma treatment preference study -: A conjoint analysis of preferred drug treatments
Berggren F; Ställberg B; Tornling G; Fält K; Andersson S; Karlsson G; Johansson G

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI